IP Library Assignment 027333/0860
Patent Assignment
Reel/Frame 027333/0860

Change of Name

Recorded: 2011-12-06 Pages: 64
Assignor
Assignee
BAYER PHARMA AKTIENGESELLSCHAFT
MUELLERSTRASSE 178, BERLIN, 13353, GERMANY
Covered Property (1)
Substituted 2,3-Dihydroimidazo[1,2-C]Quinazoline Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Angiogenesis
Patent: 8,466,283 →
Application: 12/517,875 →
Publication: US 2011/0083984
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger Dec 6, 2011
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 027341/0421 →
Assignment of Assignor's Interest May 30, 2013
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 030516/0512 →
Change of Address Jun 12, 2023
From: BAYER INTELLECTUAL PROPERTY GMBH
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 064021/0344 →